img

Global Low Molecular Weight Heparin Sodium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Low Molecular Weight Heparin Sodium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

This report mainly studies low molecular weight heparin sodium market. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the prevention of blood clots and treatment of venous thromboembolism (deep vein thrombosis and pulmonary embolism) and in the treatment of myocardial infarction.
Global Low Molecular Weight Heparin Sodium market is projected to reach US$ 6020.7 million in 2029, increasing from US$ 3896 million in 2022, with the CAGR of 6.6% during the period of 2024 to 2029. Demand from Medical and Research are the major drivers for the industry.
Factors such as increasing advantages of low molecular weight heparin overunfractionated heparin and increasing introduction of biosimilar low molecularweight heparin anticoagulants globally are expected to drive the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Low Molecular Weight Heparin Sodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutica
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Segment by Application


Medical
Research

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Low Molecular Weight Heparin Sodium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Low Molecular Weight Heparin Sodium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Low Molecular Weight Heparin Sodium industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Low Molecular Weight Heparin Sodium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Low Molecular Weight Heparin Sodium introduction, etc. Low Molecular Weight Heparin Sodium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Low Molecular Weight Heparin Sodium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Low Molecular Weight Heparin Sodium Market Overview
1.1 Low Molecular Weight Heparin Sodium Product Overview
1.2 Low Molecular Weight Heparin Sodium Market Segment by Type
1.2.1 Enoxaparin
1.2.2 Dalteparin
1.2.3 Tinzaparin
1.2.4 Fraxiparine
1.3 Global Low Molecular Weight Heparin Sodium Market Size by Type
1.3.1 Global Low Molecular Weight Heparin Sodium Market Size Overview by Type (2018-2029)
1.3.2 Global Low Molecular Weight Heparin Sodium Historic Market Size Review by Type (2018-2024)
1.3.3 Global Low Molecular Weight Heparin Sodium Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Low Molecular Weight Heparin Sodium Sales Breakdown by Type (2018-2024)
1.4.2 Europe Low Molecular Weight Heparin Sodium Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Low Molecular Weight Heparin Sodium Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Low Molecular Weight Heparin Sodium Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Low Molecular Weight Heparin Sodium Sales Breakdown by Type (2018-2024)
2 Global Low Molecular Weight Heparin Sodium Market Competition by Company
2.1 Global Top Players by Low Molecular Weight Heparin Sodium Sales (2018-2024)
2.2 Global Top Players by Low Molecular Weight Heparin Sodium Revenue (2018-2024)
2.3 Global Top Players by Low Molecular Weight Heparin Sodium Price (2018-2024)
2.4 Global Top Manufacturers Low Molecular Weight Heparin Sodium Manufacturing Base Distribution, Sales Area, Product Type
2.5 Low Molecular Weight Heparin Sodium Market Competitive Situation and Trends
2.5.1 Low Molecular Weight Heparin Sodium Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Low Molecular Weight Heparin Sodium Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin Sodium as of 2022)
2.7 Date of Key Manufacturers Enter into Low Molecular Weight Heparin Sodium Market
2.8 Key Manufacturers Low Molecular Weight Heparin Sodium Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Low Molecular Weight Heparin Sodium Status and Outlook by Region
3.1 Global Low Molecular Weight Heparin Sodium Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Low Molecular Weight Heparin Sodium Historic Market Size by Region
3.2.1 Global Low Molecular Weight Heparin Sodium Sales in Volume by Region (2018-2024)
3.2.2 Global Low Molecular Weight Heparin Sodium Sales in Value by Region (2018-2024)
3.2.3 Global Low Molecular Weight Heparin Sodium Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Low Molecular Weight Heparin Sodium Forecasted Market Size by Region
3.3.1 Global Low Molecular Weight Heparin Sodium Sales in Volume by Region (2024-2029)
3.3.2 Global Low Molecular Weight Heparin Sodium Sales in Value by Region (2024-2029)
3.3.3 Global Low Molecular Weight Heparin Sodium Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Low Molecular Weight Heparin Sodium by Application
4.1 Low Molecular Weight Heparin Sodium Market Segment by Application
4.1.1 Medical
4.1.2 Research
4.2 Global Low Molecular Weight Heparin Sodium Market Size by Application
4.2.1 Global Low Molecular Weight Heparin Sodium Market Size Overview by Application (2018-2029)
4.2.2 Global Low Molecular Weight Heparin Sodium Historic Market Size Review by Application (2018-2024)
4.2.3 Global Low Molecular Weight Heparin Sodium Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Low Molecular Weight Heparin Sodium Sales Breakdown by Application (2018-2024)
4.3.2 Europe Low Molecular Weight Heparin Sodium Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Low Molecular Weight Heparin Sodium Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Low Molecular Weight Heparin Sodium Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Low Molecular Weight Heparin Sodium Sales Breakdown by Application (2018-2024)
5 North America Low Molecular Weight Heparin Sodium by Country
5.1 North America Low Molecular Weight Heparin Sodium Historic Market Size by Country
5.1.1 North America Low Molecular Weight Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Low Molecular Weight Heparin Sodium Sales in Volume by Country (2018-2024)
5.1.3 North America Low Molecular Weight Heparin Sodium Sales in Value by Country (2018-2024)
5.2 North America Low Molecular Weight Heparin Sodium Forecasted Market Size by Country
5.2.1 North America Low Molecular Weight Heparin Sodium Sales in Volume by Country (2024-2029)
5.2.2 North America Low Molecular Weight Heparin Sodium Sales in Value by Country (2024-2029)
6 Europe Low Molecular Weight Heparin Sodium by Country
6.1 Europe Low Molecular Weight Heparin Sodium Historic Market Size by Country
6.1.1 Europe Low Molecular Weight Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Low Molecular Weight Heparin Sodium Sales in Volume by Country (2018-2024)
6.1.3 Europe Low Molecular Weight Heparin Sodium Sales in Value by Country (2018-2024)
6.2 Europe Low Molecular Weight Heparin Sodium Forecasted Market Size by Country
6.2.1 Europe Low Molecular Weight Heparin Sodium Sales in Volume by Country (2024-2029)
6.2.2 Europe Low Molecular Weight Heparin Sodium Sales in Value by Country (2024-2029)
7 Asia-Pacific Low Molecular Weight Heparin Sodium by Region
7.1 Asia-Pacific Low Molecular Weight Heparin Sodium Historic Market Size by Region
7.1.1 Asia-Pacific Low Molecular Weight Heparin Sodium Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Low Molecular Weight Heparin Sodium Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Low Molecular Weight Heparin Sodium Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Low Molecular Weight Heparin Sodium Forecasted Market Size by Region
7.2.1 Asia-Pacific Low Molecular Weight Heparin Sodium Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Low Molecular Weight Heparin Sodium Sales in Value by Region (2024-2029)
8 Latin America Low Molecular Weight Heparin Sodium by Country
8.1 Latin America Low Molecular Weight Heparin Sodium Historic Market Size by Country
8.1.1 Latin America Low Molecular Weight Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Low Molecular Weight Heparin Sodium Sales in Volume by Country (2018-2024)
8.1.3 Latin America Low Molecular Weight Heparin Sodium Sales in Value by Country (2018-2024)
8.2 Latin America Low Molecular Weight Heparin Sodium Forecasted Market Size by Country
8.2.1 Latin America Low Molecular Weight Heparin Sodium Sales in Volume by Country (2024-2029)
8.2.2 Latin America Low Molecular Weight Heparin Sodium Sales in Value by Country (2024-2029)
9 Middle East and Africa Low Molecular Weight Heparin Sodium by Country
9.1 Middle East and Africa Low Molecular Weight Heparin Sodium Historic Market Size by Country
9.1.1 Middle East and Africa Low Molecular Weight Heparin Sodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Low Molecular Weight Heparin Sodium Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Low Molecular Weight Heparin Sodium Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Low Molecular Weight Heparin Sodium Forecasted Market Size by Country
9.2.1 Middle East and Africa Low Molecular Weight Heparin Sodium Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Low Molecular Weight Heparin Sodium Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Aspen
10.1.1 Aspen Company Information
10.1.2 Aspen Introduction and Business Overview
10.1.3 Aspen Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Aspen Low Molecular Weight Heparin Sodium Products Offered
10.1.5 Aspen Recent Development
10.2 Sanofi-aventis
10.2.1 Sanofi-aventis Company Information
10.2.2 Sanofi-aventis Introduction and Business Overview
10.2.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi-aventis Low Molecular Weight Heparin Sodium Products Offered
10.2.5 Sanofi-aventis Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Low Molecular Weight Heparin Sodium Products Offered
10.3.5 Pfizer Recent Development
10.4 Opocrin
10.4.1 Opocrin Company Information
10.4.2 Opocrin Introduction and Business Overview
10.4.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Opocrin Low Molecular Weight Heparin Sodium Products Offered
10.4.5 Opocrin Recent Development
10.5 CSBIO
10.5.1 CSBIO Company Information
10.5.2 CSBIO Introduction and Business Overview
10.5.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CSBIO Low Molecular Weight Heparin Sodium Products Offered
10.5.5 CSBIO Recent Development
10.6 Dongying Tiandong Pharmaceutica
10.6.1 Dongying Tiandong Pharmaceutica Company Information
10.6.2 Dongying Tiandong Pharmaceutica Introduction and Business Overview
10.6.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Products Offered
10.6.5 Dongying Tiandong Pharmaceutica Recent Development
10.7 Changzhou Qianhong Bio-pharma
10.7.1 Changzhou Qianhong Bio-pharma Company Information
10.7.2 Changzhou Qianhong Bio-pharma Introduction and Business Overview
10.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Products Offered
10.7.5 Changzhou Qianhong Bio-pharma Recent Development
10.8 Techdow
10.8.1 Techdow Company Information
10.8.2 Techdow Introduction and Business Overview
10.8.3 Techdow Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Techdow Low Molecular Weight Heparin Sodium Products Offered
10.8.5 Techdow Recent Development
10.9 Yantai Dongcheng Pharmaceutical Group
10.9.1 Yantai Dongcheng Pharmaceutical Group Company Information
10.9.2 Yantai Dongcheng Pharmaceutical Group Introduction and Business Overview
10.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Products Offered
10.9.5 Yantai Dongcheng Pharmaceutical Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Low Molecular Weight Heparin Sodium Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Low Molecular Weight Heparin Sodium Industrial Chain Analysis
11.4 Low Molecular Weight Heparin Sodium Market Dynamics
11.4.1 Low Molecular Weight Heparin Sodium Industry Trends
11.4.2 Low Molecular Weight Heparin Sodium Market Drivers
11.4.3 Low Molecular Weight Heparin Sodium Market Challenges
11.4.4 Low Molecular Weight Heparin Sodium Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Low Molecular Weight Heparin Sodium Distributors
12.3 Low Molecular Weight Heparin Sodium Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Enoxaparin
Table 2. Major Company of Dalteparin
Table 3. Major Company of Tinzaparin
Table 4. Major Company of Fraxiparine
Table 5. Global Low Molecular Weight Heparin Sodium Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (K MT)
Table 7. Global Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (US& Million)
Table 9. Global Low Molecular Weight Heparin Sodium Market Share in Value by Type (2018-2024)
Table 10. Global Low Molecular Weight Heparin Sodium Price by Type (2018-2024) & (USD/MT)
Table 11. Global Low Molecular Weight Heparin Sodium Sales by Type (2024-2029) & (K MT)
Table 12. Global Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Low Molecular Weight Heparin Sodium Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Low Molecular Weight Heparin Sodium Sales Market Share in Value by Type (2024-2029)
Table 15. Global Low Molecular Weight Heparin Sodium Price by Type (2024-2029) & (USD/MT)
Table 16. North America Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (K MT)
Table 17. North America Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Low Molecular Weight Heparin Sodium Sales (K MT) by Type (2018-2024)
Table 19. Europe Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Low Molecular Weight Heparin Sodium Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Low Molecular Weight Heparin Sodium Sales (K MT) by Type (2018-2024)
Table 23. Latin America Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Low Molecular Weight Heparin Sodium Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Low Molecular Weight Heparin Sodium Sales by Company (2018-2024) & (K MT)
Table 27. Global Low Molecular Weight Heparin Sodium Sales Share by Company (2018-2024)
Table 28. Global Low Molecular Weight Heparin Sodium Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Low Molecular Weight Heparin Sodium Revenue Share by Company (2018-2024)
Table 30. Global Market Low Molecular Weight Heparin Sodium Price by Company (2018-2024) & (USD/MT)
Table 31. Global Low Molecular Weight Heparin Sodium Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Low Molecular Weight Heparin Sodium Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Low Molecular Weight Heparin Sodium as of 2022)
Table 34. Date of Key Manufacturers Enter into Low Molecular Weight Heparin Sodium Market
Table 35. Key Manufacturers Low Molecular Weight Heparin Sodium Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Low Molecular Weight Heparin Sodium Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Low Molecular Weight Heparin Sodium Sales by Region (2018-2024) & (K MT)
Table 39. Global Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Low Molecular Weight Heparin Sodium Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Low Molecular Weight Heparin Sodium Sales Market Share in Value by Region (2018-2024)
Table 42. Global Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Low Molecular Weight Heparin Sodium Sales by Region (2024-2029) & (K MT)
Table 44. Global Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Low Molecular Weight Heparin Sodium Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Low Molecular Weight Heparin Sodium Sales Market Share in Value by Region (2024-2029)
Table 47. Global Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 48. Global Low Molecular Weight Heparin Sodium Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (K MT)
Table 50. Global Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application (2018-2024)
Table 53. Global Low Molecular Weight Heparin Sodium Price by Application (2018-2024) & (USD/MT)
Table 54. Global Low Molecular Weight Heparin Sodium Sales by Application (2024-2029) & (K MT)
Table 55. Global Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Low Molecular Weight Heparin Sodium Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application (2024-2029)
Table 58. Global Low Molecular Weight Heparin Sodium Price by Application (2024-2029) & (USD/MT)
Table 59. North America Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) (K MT)
Table 60. North America Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) (K MT)
Table 62. Europe Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) (K MT)
Table 66. Latin America Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 70. North America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2018-2024)
Table 73. North America Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 74. North America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 78. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 82. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Region (2024-2029) & (K MT)
Table 90. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Low Molecular Weight Heparin Sodium Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 98. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (K MT)
Table 106. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Value by Country (2024-2029)
Table 109. Aspen Company Information
Table 110. Aspen Introduction and Business Overview
Table 111. Aspen Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. Aspen Low Molecular Weight Heparin Sodium Product
Table 113. Aspen Recent Development
Table 114. Sanofi-aventis Company Information
Table 115. Sanofi-aventis Introduction and Business Overview
Table 116. Sanofi-aventis Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Sanofi-aventis Low Molecular Weight Heparin Sodium Product
Table 118. Sanofi-aventis Recent Development
Table 119. Pfizer Company Information
Table 120. Pfizer Introduction and Business Overview
Table 121. Pfizer Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Pfizer Low Molecular Weight Heparin Sodium Product
Table 123. Pfizer Recent Development
Table 124. Opocrin Company Information
Table 125. Opocrin Introduction and Business Overview
Table 126. Opocrin Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Opocrin Low Molecular Weight Heparin Sodium Product
Table 128. Opocrin Recent Development
Table 129. CSBIO Company Information
Table 130. CSBIO Introduction and Business Overview
Table 131. CSBIO Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. CSBIO Low Molecular Weight Heparin Sodium Product
Table 133. CSBIO Recent Development
Table 134. Dongying Tiandong Pharmaceutica Company Information
Table 135. Dongying Tiandong Pharmaceutica Introduction and Business Overview
Table 136. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product
Table 138. Dongying Tiandong Pharmaceutica Recent Development
Table 139. Changzhou Qianhong Bio-pharma Company Information
Table 140. Changzhou Qianhong Bio-pharma Introduction and Business Overview
Table 141. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 142. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product
Table 143. Changzhou Qianhong Bio-pharma Recent Development
Table 144. Techdow Company Information
Table 145. Techdow Introduction and Business Overview
Table 146. Techdow Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 147. Techdow Low Molecular Weight Heparin Sodium Product
Table 148. Techdow Recent Development
Table 149. Yantai Dongcheng Pharmaceutical Group Company Information
Table 150. Yantai Dongcheng Pharmaceutical Group Introduction and Business Overview
Table 151. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 152. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product
Table 153. Yantai Dongcheng Pharmaceutical Group Recent Development
Table 154. Key Raw Materials Lists
Table 155. Raw Materials Key Suppliers Lists
Table 156. Low Molecular Weight Heparin Sodium Market Trends
Table 157. Low Molecular Weight Heparin Sodium Market Drivers
Table 158. Low Molecular Weight Heparin Sodium Market Challenges
Table 159. Low Molecular Weight Heparin Sodium Market Restraints
Table 160. Low Molecular Weight Heparin Sodium Distributors List
Table 161. Low Molecular Weight Heparin Sodium Downstream Customers
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Low Molecular Weight Heparin Sodium Product Picture
Figure 2. Global Low Molecular Weight Heparin Sodium Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Low Molecular Weight Heparin Sodium Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Low Molecular Weight Heparin Sodium Sales Status and Outlook (2018-2029) & (K MT)
Figure 5. Product Picture of Enoxaparin
Figure 6. Global Enoxaparin Sales YoY Growth (2018-2029) & (K MT)
Figure 7. Product Picture of Dalteparin
Figure 8. Global Dalteparin Sales YoY Growth (2018-2029) & (K MT)
Figure 9. Product Picture of Tinzaparin
Figure 10. Global Tinzaparin Sales YoY Growth (2018-2029) & (K MT)
Figure 11. Product Picture of Fraxiparine
Figure 12. Global Fraxiparine Sales YoY Growth (2018-2029) & (K MT)
Figure 13. Global Low Molecular Weight Heparin Sodium Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type in 2022 & 2029
Figure 15. North America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type in 2022
Figure 16. North America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Type in 2022
Figure 17. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type in 2022
Figure 18. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Value by Type in 2022
Figure 21. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Low Molecular Weight Heparin Sodium Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Low Molecular Weight Heparin Sodium Revenue in 2022
Figure 27. Low Molecular Weight Heparin Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Medical
Figure 29. Global Medical Sales YoY Growth (2018-2029) & (K MT)
Figure 30. Product Picture of Research
Figure 31. Global Research Sales YoY Growth (2018-2029) & (K MT)
Figure 32. Global Low Molecular Weight Heparin Sodium Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application in 2022 & 2029
Figure 34. North America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Application in 2022
Figure 35. North America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application in 2022
Figure 36. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Application in 2022
Figure 37. Europe Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application in 2022
Figure 40. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Low Molecular Weight Heparin Sodium Manufacturing Cost Structure
Figure 45. Low Molecular Weight Heparin Sodium Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed